Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

Abstract:

:Liver injury is a frequent, serious complication of allogeneic hematopoietic cell transplantation (HCT) following myeloablative preparative regimens. We sought to determine the frequency and severity of hepatic injury after nonmyeloablative conditioning and its relationship to outcomes. One hundred ninety-three consecutive patients who received 2 Gy total body irradiation with or without fludarabine were evaluated for end points related to liver injury. Patients with diseases treatable by HCT who were ineligible for conventional myeloablative allogeneic HCT because of advanced age and/or comorbid conditions were included. Fifty-one patients (26%) developed hyperbilirubinemia of 68.4 microM (4 mg/dL) or greater, most commonly resulting from cholestasis due to graft-versus-host disease (GVHD) or sepsis. Pretransplantation factors associated with liver dysfunction were a diagnosis of aggressive malignancy (hazard ratio [HR] 1.9; P =.04) and the inclusion of fludarabine in the conditioning regimen (HR 1.8; P =.07). Overall survival at 1 year was superior for patients who had maximal serum bilirubin levels in the normal (78%) or minimally elevated (22.23-66.69 microM [1.3-3.9 mg/dL]) ranges (69%) compared with those in the 68.4 to 117.99 microM (4-6.9 mg/dL; 20%), 119.7 to 169.29 microM (7.0-9.9 mg/dL; 17%), and 171.0 microM (10 mg/dL; 19%) or greater groups. In summary, significant jaundice occurred in 26% of patients and was predominantly due to cholestasis resulting from GVHD and/or sepsis. Aggressive malignancies (mainly advanced disease) and later development of jaundice after transplantation predicted inferior survival.

journal_name

Blood

journal_title

Blood

authors

Hogan WJ,Maris M,Storer B,Sandmaier BM,Maloney DG,Schoch HG,Woolfrey AE,Shulman HM,Storb R,McDonald GB

doi

10.1182/blood-2003-04-1311

subject

Has Abstract

pub_date

2004-01-01 00:00:00

pages

78-84

issue

1

eissn

0006-4971

issn

1528-0020

pii

2003-04-1311

journal_volume

103

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.

    abstract::The PAX-5 gene codes for the transcription factor BSAP, which is expressed throughout B-cell development. Although loss-of-function mutation in the mouse showed an essential role for Pax-5 in early B lymphopoiesis, gain-of-function mutations have implicated the human PAX-5 gene in the control of late B-cell differenti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morrison AM,Jäger U,Chott A,Schebesta M,Haas OA,Busslinger M

    更新日期:1998-11-15 00:00:00

  • CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6.

    abstract::Regulated adherence of polymorphonuclear leukocytes (PMNs) to endothelium and subendothelial matrix is a critical event for PMN localization at and migration into inflammatory sites. We previously reported that human PMNs stimulated in vitro adhere to laminin, the major glycoprotein of mammalian basement membrane, by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bohnsack JF

    更新日期:1992-03-15 00:00:00

  • Electrolyte and acid-base disturbances in the management of leukemia.

    abstract::Electrolyte disturbances in leukemia can be the result of the disease process or drug therapy. One group of electrolyte abnormalities is related to the stage of the leukemic process. Included in this group are newly diagnosed patients who may show elevated serum potassium, phosphorus, and magnesium--a result of their ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: O'Regan S,Carson S,Chesney RW,Drummond KN

    更新日期:1977-03-01 00:00:00

  • MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

    abstract::MicroRNAs (miRNAs) have emerged as important regulators of the immune system. However, despite this prominence, our understanding of the function of miRNAs in the early hematopoietic stages is incomplete. In this study, we found that miR-139-5p negatively regulated the proliferation of hematopoietic stem cells and pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-02-702464

    authors: Choi J,Kim YK,Park K,Nah J,Yoon SS,Kim DW,Kim VN,Seong RH

    更新日期:2016-10-27 00:00:00

  • Fetal erythropoiesis following bone marrow transplantation.

    abstract::"Fetal" erythrocytes are present in older children and certain adults with hematologic disorders. To determine if regenerating bone marrow produces such cells, we examined the blood of seven allogeneic bone marrow transplant recipients. Six patients were engrafted with donor cells, while on e patients recovered autolo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alter BP,Rappeport JM,Huisman TH,Schroeder WA,Nathan DG

    更新日期:1976-12-01 00:00:00

  • Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach.

    abstract::Hematopoietic stem cells (HSCs) show pronounced heterogeneity in self-renewal and differentiation behavior, which is reflected in their repopulation kinetics. Here, a single-cell-based mathematical model of HSC organization is used to examine the basis of HSC heterogeneity. Our modeling results, which are based on the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-155374

    authors: Roeder I,Horn K,Sieburg HB,Cho R,Muller-Sieburg C,Loeffler M

    更新日期:2008-12-15 00:00:00

  • Role for MKL1 in megakaryocytic maturation.

    abstract::Megakaryoblastic leukemia 1 (MKL1), identified as part of the t(1;22) translocation specific to acute megakaryoblastic leukemia, is highly expressed in differentiated muscle cells and promotes muscle differentiation by activating serum response factor (SRF). Here we show that Mkl1 expression is up-regulated during mur...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-180596

    authors: Cheng EC,Luo Q,Bruscia EM,Renda MJ,Troy JA,Massaro SA,Tuck D,Schulz V,Mane SM,Berliner N,Sun Y,Morris SW,Qiu C,Krause DS

    更新日期:2009-03-19 00:00:00

  • Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6.

    abstract::NF-IL6 was originally identified as a DNA binding protein regulating interleukin-1 (IL-1)-stimulated IL-6 expression. Direct cloning of NF-IL6 showed its homology with C/EBP, a hepatocyte- and adipocyte-specific transcription factor. This study showed that the expression of NF-IL6 messenger RNA (mRNA) increased marked...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Natsuka S,Akira S,Nishio Y,Hashimoto S,Sugita T,Isshiki H,Kishimoto T

    更新日期:1992-01-15 00:00:00

  • Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.

    abstract::Six hundred twelve eligible, previously untreated patients with active multiple myeloma and at least some data available for analysis were entered into a randomized trial (Southwest Oncology Group [SWOG] Phase III myeloma study 8229/30), in which the prognostic significance of pretreatment serum beta 2 microglobulin l...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Durie BG,Stock-Novack D,Salmon SE,Finley P,Beckord J,Crowley J,Coltman CA

    更新日期:1990-02-15 00:00:00

  • Quantitation of adenosine-5'-triphosphate used for phosphoinositide metabolism in human erythrocytes.

    abstract::The human erythrocyte actively phosphorylates and dephosphorylates phosphatidylinositol present in the membrane in an apparent "futile cycle." Recent reports have proposed that this phosphorylation/dephosphorylation cycle is a significant consumer of adenosine-5'-triphosphate (ATP) in the erythrocyte. This study detai...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dale GL

    更新日期:1985-11-01 00:00:00

  • In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.

    abstract::Recent findings implied that the progression of hematologic malignancies, like that of solid tumors, is dependent on neovascularization. Recent studies on patients with acute myeloid leukemia (AML) showed increased levels of leukocyte-associated vascular endothelial growth factor (VEGF) and neovascularization of the b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.V100.13.4622

    authors: Schuch G,Machluf M,Bartsch G Jr,Nomi M,Richard H,Atala A,Soker S

    更新日期:2002-12-15 00:00:00

  • A deletion mutation causes hemophilia B in Lhasa Apso dogs.

    abstract::Hemophilia B is a bleeding disorder caused by a deficiency of clotting factor IX (FIX). A colony of FIX deficient Lhasa Apso dogs has been established and the molecular basis of hemophilia B has been determined. The plasma factor IX levels were < 1% of normal canine levels in affected dogs. A complex deletion mutation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mauser AE,Whitlark J,Whitney KM,Lothrop CD Jr

    更新日期:1996-11-01 00:00:00

  • Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children.

    abstract::Increased apoptosis of CD4+ T cells is considered to be involved in CD4+ T-cell depletion in human immunodeficiency virus type-1 (HIV-1)-infected individuals progressing toward acquired immunodeficiency syndrome (AIDS). We have recently shown that CD95 (APO-1/Fas) expression is strongly increased in T cells of HIV-1-i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bäumler CB,Böhler T,Herr I,Benner A,Krammer PH,Debatin KM

    更新日期:1996-09-01 00:00:00

  • Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

    abstract::Fanconi anemia (FA) is an autosomal recessive syndrome featuring diverse symptoms including progressive bone marrow failure and early occurrence of acute myeloid leukemia. Nine genetic subtypes have been described for FA (A, B, C, D1, D2, E, F, G, and L), all of which have been connected to distinct disease genes, exc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2915

    authors: Levitus M,Rooimans MA,Steltenpool J,Cool NF,Oostra AB,Mathew CG,Hoatlin ME,Waisfisz Q,Arwert F,de Winter JP,Joenje H

    更新日期:2004-04-01 00:00:00

  • Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.

    abstract::Lumiliximab is a chimeric macaque-human monoclonal antibody to CD23, a protein expressed on virtually all chronic lymphocytic leukemia (CLL) cells. We examined the ability of lumiliximab to mediate apoptosis, antibody-dependent cellular cytotoxicity, and complement-dependent cytotoxicity against primary CLL cells and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-082024

    authors: Pathan NI,Chu P,Hariharan K,Cheney C,Molina A,Byrd J

    更新日期:2008-02-01 00:00:00

  • SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells.

    abstract::In Wiskott-Aldrich syndrome (WAS), immunodeficiency and autoimmunity often comanifest, yet how WAS mutations misregulate chromatin-signaling in Thelper (TH) cells favoring development of auto-inflammation over protective immunity is unclear. Previously, we identified an essential promoter-specific, coactivator role of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-05-646182

    authors: Sarkar K,Sadhukhan S,Han SS,Vyas YM

    更新日期:2015-10-01 00:00:00

  • Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates.

    abstract::Approximately 30% to 40% of patients with acute leukemia receiving repeated pooled random-donor platelet transfusions develop anti-HLA alloantibodies. Over time, however, serum anti-HLA concentrations decrease in approximately 50% of these patients, despite continued exposure to platelet and/or red blood cell transfus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Atlas E,Freedman J,Blanchette V,Kazatchkine MD,Semple JW

    更新日期:1993-01-15 00:00:00

  • Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota.

    abstract::Bone marrow suppression is an adverse effect associated with many antibiotics, especially when administered for prolonged treatment courses. Recent advances in our understanding of steady-state hematopoiesis have allowed us to explore the effects of antibiotics on hematopoietic progenitors in detail using a murine mod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-03-708594

    authors: Josefsdottir KS,Baldridge MT,Kadmon CS,King KY

    更新日期:2017-02-09 00:00:00

  • Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

    abstract::During an 8-year period, 3,638 children from institutions of the Pediatric Oncology Group (POG) were diagnosed with acute lymphoblastic leukemia (ALL). Fifty-seven patients had Philadelphia chromosome-positive (Ph1) ALL. Blast cells obtained at diagnosis from 13 of these 57 cases (23%) were also found to have partial ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Russo C,Carroll A,Kohler S,Borowitz M,Amylon M,Homans A,Kedar A,Shuster J,Land V,Crist W

    更新日期:1991-03-01 00:00:00

  • How I treat essential thrombocythemia.

    abstract::In the past 5 years we have witnessed significant advances in both the diagnostic process and optimal therapy for patients with essential thrombocythemia (ET). Insights into the underlying molecular mechanisms have been accompanied by the development of new diagnostic tests and by an improved understanding of the rela...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-270033

    authors: Beer PA,Erber WN,Campbell PJ,Green AR

    更新日期:2011-02-03 00:00:00

  • Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia.

    abstract::The mechanisms of resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) often remain obscure. Analysis of patient samples during disease progression revealed the up-regulation of the oncogene TWIST-1, also measured in primary samples from TKI-resistant patients. Moreover, we found that TWIS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-11-254680

    authors: Cosset E,Hamdan G,Jeanpierre S,Voeltzel T,Sagorny K,Hayette S,Mahon FX,Dumontet C,Puisieux A,Nicolini FE,Maguer-Satta V

    更新日期:2011-02-03 00:00:00

  • Exploiting the kinetic interplay between GPIbα-VWF binding interfaces to regulate hemostasis and thrombosis.

    abstract::Platelet-von Willebrand factor (VWF) interactions must be tightly regulated in order to promote effective hemostasis and prevent occlusive thrombus formation. However, it is unclear what role the inherent properties of the bond formed between the platelet receptor glycoprotein Ibα and the A1 domain of VWF play in thes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-569392

    authors: Chen J,Zhou H,Diacovo A,Zheng XL,Emsley J,Diacovo TG

    更新日期:2014-12-11 00:00:00

  • Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients.

    abstract::We infused six human immunodeficiency virus (HIV)-seropositive subjects with autologous CD8+ cytotoxic T cells (CTLs) enriched for HIV-specific cytotoxicity targeted against a diversity of HIV epitopes in gp120, gag p17 and p24, and nef. There was no toxicity and no subject deteriorated clinically. In the first 2 week...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Lieberman J,Skolnik PR,Parkerson GR 3rd,Fabry JA,Landry B,Bethel J,Kagan J

    更新日期:1997-09-15 00:00:00

  • Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells.

    abstract::We demonstrate here that EL4-6.1 cells, a mouse thymoma that expresses high levels of membrane interleukin (IL)-1 receptors, produce IL-1 beta as an autocrine regulatory factor. Endogenous IL-1 beta sustains both proliferation and apoptosis: during the exponential phase, it mainly promotes proliferation, while during ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fratelli M,Gagliardini V,Galli G,Gnocchi P,Ghiara P,Ghezzi P

    更新日期:1995-06-15 00:00:00

  • Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.

    abstract::The prognostic implications of t(9;22)(q34;q11) were assessed at a median follow-up of 3.5 years in 434 children receiving intensive treatment for acute lymphoblastic leukemia (ALL). Four-year event-free and overall survivals were 81% and 88%, respectively, in 419 children lacking t(9;22), but were 0% and 20%, respect...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Fletcher JA,Lynch EA,Kimball VM,Donnelly M,Tantravahi R,Sallan SE

    更新日期:1991-02-01 00:00:00

  • The effect of recombinant erythropoietin on intracellular free calcium in erythropoietin-responsive cells.

    abstract::We have investigated whether recombinant erythropoietin (r-Epo) elicits a change in intracellular free calcium (IFC) in purified Epo-responsive cells in spleens of mice treated with phenylhydrazine. Colony-forming units (CFU-E) were prepared by negative selection through immunologic panning. Anti-Forssman, Mac-1, Ia, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Imagawa S,Smith BR,Palmer-Crocker R,Bunn HF

    更新日期:1989-05-01 00:00:00

  • Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

    abstract::Diverse human cancers with poor prognosis, including many lymphoid and myeloid malignancies, exhibit high levels of Mcl-1. To explore the impact of Mcl-1 overexpression on the hematopoietic compartment, we have generated vavP-Mcl-1 transgenic mice. Their lymphoid and myeloid cells displayed increased resistance to a v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-281071

    authors: Campbell KJ,Bath ML,Turner ML,Vandenberg CJ,Bouillet P,Metcalf D,Scott CL,Cory S

    更新日期:2010-10-28 00:00:00

  • The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.

    abstract::The treatment of multiple myeloma has evolved significantly over the last decades from primarily alkylator-based chemotherapeutic agents with minimal efficacy to the introduction of more effective agents including immune modulators and proteasome inhibitors, which have changed the landscape of therapy for this disease...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-05-636357

    authors: Hoyos V,Borrello I

    更新日期:2016-09-29 00:00:00

  • TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release.

    abstract::Exposure of endothelial cells to recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced a modest (2-fold) increase of HL-60 cell adhesion as compared to TNF-alpha (40-fold) or interleukin 1beta (IL-1beta; 20-fold). However, pretreatment of endothelial cultures with TRAIL determined a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-4111

    authors: Secchiero P,Corallini F,di Iasio MG,Gonelli A,Barbarotto E,Zauli G

    更新日期:2005-05-01 00:00:00

  • High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.

    abstract::Forty patients with refractory Hodgkin's disease (24 patients) or non-Hodgkin's lymphoma (16 patients) who were considered for high-dose therapy but not for autologous bone marrow transplantation (ABMT) due to BM metastases, previous pelvic irradiation, a history of marrow involvement by tumor or hypocellular marrow i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kessinger A,Armitage JO,Smith DM,Landmark JD,Bierman PJ,Weisenburger DD

    更新日期:1989-09-01 00:00:00